Related Experiment Video

Updated: Jul 22, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

41.1K

Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection

Hao-Tian Liu1, Zhi-Cheng Li1, Chuan Li1

  • 1Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, China.

Alimentary Pharmacology & Therapeutics
|December 17, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.2K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.7K

Related Experiment Videos

Last Updated: Jul 22, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

41.1K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.2K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.7K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Articles linked to this work by shared authors, journal, and citation graph.

Selective area growth and stencil lithography for in situ fabricated quantum devices.

Nature nanotechnology·2019

Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions.

Acta pharmacologica Sinica·2019

An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.

Cancer discovery·2019

Volatile flavour components and the mechanisms underlying their production in golden pompano (Trachinotus blochii) fillets subjected to different drying methods: A comparative study using an electronic nose, an electronic tongue and SDE-GC-MS.

Food research international (Ottawa, Ont.)·2019

Cytotoxic 9,19-cycloartane Triterpenoids from the Roots of Actaea dahurica.

Fitoterapia·2019

NAT10 upregulation indicates a poor prognosis in acute myeloid leukemia.

Current problems in cancer·2019

Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.

Alimentary pharmacology & therapeutics·2026

HLA-A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection.

Alimentary pharmacology & therapeutics·2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Alimentary pharmacology & therapeutics·2026

Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer.

Alimentary pharmacology & therapeutics·2026

Pharmacokinetic and Pharmacodynamic Variability Predict Late Events After Paediatric Liver Transplantation: Derivation and External Validation of a Landmark Risk Score.

Alimentary pharmacology & therapeutics·2026

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Alimentary pharmacology & therapeutics·2026

Redo Root and RVOT Reconstruction for Destructive Citrobacter Koseri Endocarditis.

JACC. Case reports·2026

Successful Mechanical Thrombectomy Using a Stent-Retriever Device for STEMI of the Left Main Coronary Artery.

JACC. Case reports·2026

Association Between the Atherogenic Index of Plasma and the Occurrence of Slow Flow/No-Reflow in Patients With Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention.

Cardiology research and practice·2026

Surgical Versus Non-surgical Management of Acute and Subacute Infective Endocarditis in Patients With Rheumatic Heart Disease During the COVID-19 Pandemic: A Propensity-Matched Analysis.

Cureus·2026

Association Between Mineral Metabolism Abnormalities and Vascular Access Complications Among Maintenance Hemodialysis Patients in Ethiopia.

International journal of nephrology·2026

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.

Wellcome open research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us